Marcello Arca

Pubblicazioni

Titolo Pubblicato in Anno
Sex-related differences in response to lomitapide in HoFH: A subanalysis of the Pan-European Lomitapide retrospective observational study ATHEROSCLEROSIS 2025
Renal Safety Assessment of Lipid-Lowering Drugs: Between Old Certainties and New Questions DRUGS 2025
The vicious circle of chronic kidney disease and hypertriglyceridemia: What is first, the hen or the egg? ATHEROSCLEROSIS 2025
The current stage of Italy in the implementation of genomics into the National Healthcare System: an application of the B1MG maturity level model FRONTIERS IN PUBLIC HEALTH 2025
Lipid-Lowering Therapy and Cardiovascular Prevention in Elderly DRUGS 2025
Long-term experience with lomitapide treatment in patients with homozygous familial hypercholesterolemia: Over 10 years of efficacy and safety data JOURNAL OF CLINICAL LIPIDOLOGY 2025
Lomitapide-induced fatty liver is a reversible condition: evidence from a case of familial chylomicronemia syndrome JOURNAL OF CLINICAL LIPIDOLOGY 2025
Prognostic Value and Relative Cutoffs of Triglycerides Predicting Cardiovascular Outcome in a Large Regional-Based Italian Database JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE 2024
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study THE LANCET 2024
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia JAMA CARDIOLOGY 2024
Genetic heterogeneity of familial hypercholesterolaemia in two populations from two different countries EUROPEAN JOURNAL OF INTERNAL MEDICINE 2024
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY 2024
Effect of Cholesterol-Lowering Variants in ANGPTL3 and APOB Genes on Liver Disease JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 2024
Protocol for oil red O staining of low-density lipoproteins for in vivo cell treatment STAR PROTOCOLS 2024
Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY 2024
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome THE NEW ENGLAND JOURNAL OF MEDICINE 2024
How ANGPTL3 Inhibition Will Help Our Clinical Practice? CURRENT ATHEROSCLEROSIS REPORTS 2023
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia. LIVER INTERNATIONAL 2023
Effectiveness of clinical scores in predicting coronary artery disease in familial hypercholesterolemia: a coronary computed tomography angiography study LA RADIOLOGIA MEDICA 2023
[Identifying possible homozygous familial hypercholesterolemia patients: an Italian experts' opinion] GIORNALE ITALIANO DI CARDIOLOGIA 2023

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma